ID   FAT4_CAEEL              Reviewed;         447 AA.
AC   G5EG11; D5MCT8; E9P887;
DT   18-SEP-2013, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   07-APR-2021, entry version 64.
DE   RecName: Full=Delta(5) fatty acid desaturase fat-4;
DE            Short=FAT-4 {ECO:0000303|PubMed:11972048, ECO:0000303|PubMed:9845325};
DE            EC=1.14.19.37 {ECO:0000269|PubMed:9917342};
DE            EC=1.14.19.44 {ECO:0000269|PubMed:11972048, ECO:0000269|PubMed:9917342};
DE   AltName: Full=FAT-4 Delta(5) desaturase {ECO:0000303|PubMed:11972048};
DE   AltName: Full=Fatty acid desaturase 4;
GN   Name=fat-4; Synonyms=des-5; ORFNames=T13F2.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, AND PATHWAY.
RX   PubMed=9845325; DOI=10.1016/s0014-5793(98)01385-4;
RA   Michaelson L.V., Napier J.A., Lewis M., Griffiths G., Lazarus C.M.,
RA   Stobart A.K.;
RT   "Functional identification of a fatty acid delta5 desaturase gene from
RT   Caenorhabditis elegans.";
RL   FEBS Lett. 439:215-218(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RX   PubMed=9917342; DOI=10.1006/abbi.1998.1024;
RA   Watts J.L., Browse J.;
RT   "Isolation and characterization of a Delta 5-fatty acid desaturase from
RT   Caenorhabditis elegans.";
RL   Arch. Biochem. Biophys. 362:175-182(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND DISRUPTION PHENOTYPE.
RX   PubMed=11972048; DOI=10.1073/pnas.092064799;
RA   Watts J.L., Browse J.;
RT   "Genetic dissection of polyunsaturated fatty acid synthesis in
RT   Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5854-5859(2002).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=26806391; DOI=10.1016/j.bbalip.2016.01.009;
RA   Zhang Y., Wang H., Zhang J., Hu Y., Zhang L., Wu X., Su X., Li T., Zou X.,
RA   Liang B.;
RT   "The cytochrome b5 reductase HPO-19 is required for biosynthesis of
RT   polyunsaturated fatty acids in Caenorhabditis elegans.";
RL   Biochim. Biophys. Acta 1861:310-319(2016).
CC   -!- FUNCTION: Can function as a Delta(5) fatty acid desaturase and behaves
CC       as a (8-3) desaturase. Introduces a double bond in the fatty acid chain
CC       5 carbons away from carboxy terminal to biosynthesize polyunsaturated
CC       fatty acids (PUFAs) endogenously (PUFAs are essential for membrane
CC       structure and many cellular and physiological processes). Acts on a
CC       variety of substrates such as dihomo-gamma-linoleoyl-CoA ((8Z,11Z,14Z)-
CC       eicosatrienoyl-CoA, 20:3n-6) to generate arachidonoyl-CoA
CC       ((5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA, 20:4n-6). Also acts on a number
CC       of other substrates, including fatty acids that do not contain a double
CC       bond at the 8 position like (11Z,14Z,17Z)-eicosatrienoyl-CoA (20:3n-3)
CC       to produce (5Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA (20:4n-3)
CC       (PubMed:9845325, PubMed:9917342, PubMed:11972048, PubMed:26806391).
CC       Unlike plants, Caenorhabditis elegans desaturases seem to use fatty
CC       acyl-CoAs as substrates (By similarity). {ECO:0000250|UniProtKB:G5EGA5,
CC       ECO:0000269|PubMed:11972048, ECO:0000269|PubMed:26806391,
CC       ECO:0000269|PubMed:9845325, ECO:0000269|PubMed:9917342}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11Z,14Z)-eicosadienoyl-CoA + 2 [Fe(II)-cytochrome b5] + 2
CC         H(+) + O2 = (5Z,11Z,14Z)-eicosatrienoyl-CoA + 2 [Fe(III)-cytochrome
CC         b5] + 2 H2O; Xref=Rhea:RHEA:46524, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:76410,
CC         ChEBI:CHEBI:78663; EC=1.14.19.37;
CC         Evidence={ECO:0000269|PubMed:9917342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46525;
CC         Evidence={ECO:0000305|PubMed:9917342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11Z,14Z,17Z)-eicosatrienoyl-CoA + 2 [Fe(II)-cytochrome b5] +
CC         2 H(+) + O2 = (5Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA + 2 [Fe(III)-
CC         cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:46528, Rhea:RHEA-COMP:10438,
CC         Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:74328, ChEBI:CHEBI:78664; EC=1.14.19.37;
CC         Evidence={ECO:0000269|PubMed:9917342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46529;
CC         Evidence={ECO:0000305|PubMed:9917342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA + 2 [Fe(II)-cytochrome
CC         b5] + 2 H(+) + O2 = (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl-CoA + 2
CC         [Fe(III)-cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:46420, Rhea:RHEA-
CC         COMP:10438, Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:29033,
CC         ChEBI:CHEBI:29034, ChEBI:CHEBI:73862, ChEBI:CHEBI:74265;
CC         EC=1.14.19.44; Evidence={ECO:0000269|PubMed:11972048,
CC         ECO:0000305|PubMed:26806391};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46421;
CC         Evidence={ECO:0000269|PubMed:11972048, ECO:0000305|PubMed:26806391};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(8Z,11Z,14Z)-eicosatrienoyl-CoA + 2 [Fe(II)-cytochrome b5] + 2
CC         H(+) + O2 = (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 2 [Fe(III)-
CC         cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:46424, Rhea:RHEA-COMP:10438,
CC         Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:57368, ChEBI:CHEBI:74264; EC=1.14.19.44;
CC         Evidence={ECO:0000269|PubMed:11972048, ECO:0000269|PubMed:9917342,
CC         ECO:0000305|PubMed:26806391};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46425;
CC         Evidence={ECO:0000269|PubMed:11972048, ECO:0000305|PubMed:26806391,
CC         ECO:0000305|PubMed:9917342};
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:11972048, ECO:0000269|PubMed:9845325,
CC       ECO:0000269|PubMed:9917342}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a;
CC         IsoId=G5EG11-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=G5EG11-2; Sequence=VSP_047789;
CC       Name=c;
CC         IsoId=G5EG11-3; Sequence=VSP_047788;
CC   -!- DISRUPTION PHENOTYPE: The fat-4 mutants lack detectable Delta(5)-
CC       unsaturated fatty acids. {ECO:0000269|PubMed:11972048}.
CC   -!- MISCELLANEOUS: HPO-19 and T05H4.4 are cytochrome b5 reductases required
CC       for PUFA desaturation in Caenorhabditis elegans. HPO-19 knockdown or
CC       mutation alters FAT-4 desaturase activity.
CC       {ECO:0000269|PubMed:26806391}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF078796; AAC95143.1; -; mRNA.
DR   EMBL; AF114440; AAD13294.1; -; mRNA.
DR   EMBL; Z81122; CAB61031.1; -; Genomic_DNA.
DR   EMBL; Z81122; CBL43456.1; -; Genomic_DNA.
DR   EMBL; Z81122; CBZ01822.1; -; Genomic_DNA.
DR   PIR; T43319; T43319.
DR   RefSeq; NP_001255423.1; NM_001268494.1. [G5EG11-1]
DR   RefSeq; NP_001255424.1; NM_001268495.1. [G5EG11-2]
DR   RefSeq; NP_001255425.1; NM_001268496.1. [G5EG11-3]
DR   BioGRID; 42923; 1.
DR   STRING; 6239.T13F2.1a.1; -.
DR   SwissLipids; SLP:000000268; -.
DR   EPD; G5EG11; -.
DR   PaxDb; G5EG11; -.
DR   PeptideAtlas; G5EG11; -.
DR   EnsemblMetazoa; T13F2.1a.1; T13F2.1a.1; WBGene00001396. [G5EG11-1]
DR   EnsemblMetazoa; T13F2.1a.2; T13F2.1a.2; WBGene00001396. [G5EG11-1]
DR   EnsemblMetazoa; T13F2.1b.1; T13F2.1b.1; WBGene00001396. [G5EG11-2]
DR   EnsemblMetazoa; T13F2.1c.1; T13F2.1c.1; WBGene00001396. [G5EG11-3]
DR   EnsemblMetazoa; T13F2.1c.2; T13F2.1c.2; WBGene00001396. [G5EG11-3]
DR   EnsemblMetazoa; T13F2.1c.3; T13F2.1c.3; WBGene00001396. [G5EG11-3]
DR   GeneID; 177819; -.
DR   KEGG; cel:CELE_T13F2.1; -.
DR   CTD; 177819; -.
DR   WormBase; T13F2.1a; CE25113; WBGene00001396; fat-4. [G5EG11-1]
DR   WormBase; T13F2.1b; CE44752; WBGene00001396; fat-4. [G5EG11-2]
DR   WormBase; T13F2.1c; CE45810; WBGene00001396; fat-4. [G5EG11-3]
DR   eggNOG; KOG4232; Eukaryota.
DR   GeneTree; ENSGT00950000182990; -.
DR   HOGENOM; CLU_016265_1_1_1; -.
DR   InParanoid; G5EG11; -.
DR   OMA; MITFYIR; -.
DR   OrthoDB; 1060606at2759; -.
DR   PhylomeDB; G5EG11; -.
DR   Reactome; R-CEL-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-CEL-2046106; alpha-linolenic acid (ALA) metabolism.
DR   UniPathway; UPA00658; -.
DR   PRO; PR:G5EG11; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00001396; Expressed in adult organism and 5 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004768; F:stearoyl-CoA 9-desaturase activity; IDA:WormBase.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IMP:WormBase.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR012171; Fatty_acid_desaturase.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   PIRSF; PIRSF015921; FA_sphinglp_des; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Oxidoreductase;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..447
FT                   /note="Delta(5) fatty acid desaturase fat-4"
FT                   /id="PRO_0000423386"
FT   TRANSMEM        137..157
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        257..277
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        292..312
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        319..339
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1..80
FT                   /note="Cytochrome b5 heme-binding"
FT   VAR_SEQ         1..392
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047788"
FT   VAR_SEQ         1..91
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047789"
SQ   SEQUENCE   447 AA;  52348 MW;  D7E09CE0E2975015 CRC64;
     MVLREQEHEP FFIKIDGKWC QIDDAVLRSH PGGSAITTYK NMDATTVFHT FHTGSKEAYQ
     WLTELKKECP TQEPEIPDIK DDPIKGIDDV NMGTFNISEK RSAQINKSFT DLRMRVRAEG
     LMDGSPLFYI RKILETIFTI LFAFYLQYHT YYLPSAILMG VAWQQLGWLI HEFAHHQLFK
     NRYYNDLASY FVGNFLQGFS SGGWKEQHNV HHAATNVVGR DGDLDLVPFY ATVAEHLNNY
     SQDSWVMTLF RWQHVHWTFM LPFLRLSWLL QSIIFVSQMP THYYDYYRNT AIYEQVGLSL
     HWAWSLGQLY FLPDWSTRIM FFLVSHLVGG FLLSHVVTFN HYSVEKFALS SNIMSNYACL
     QIMTTRNMRP GRFIDWLWGG LNYQIEHHLF PTMPRHNLNT VMPLVKEFAA ANGLPYMVDD
     YFTGFWLEIE QFRNIANVAA KLTKKIA
//
